Meyka Pro banner
Bruker Corporation

Bruker Corporation (BRKRP) Stock Overview

Explore Bruker Corporation’s financial performance, market position, analyst ratings, and future outlook.

BRKRPNASDAQ
HealthcareMedical - Devices
$439.40
$1.21(0.27%)
U.S. Market opens in 41h 46m

Bruker Corporation (BRKRP)

Meyka AI Score

Z

Key Financials

Market Cap8.8B
P/E Ratio-84.78
EPS (TTM)$1.84
ROE-0.03%
Fundamental Analysis

AI Price Forecasts

1 Month$442.26
3 Months$510.26
1 Year Target$546.31

BRKRP Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Bruker Corporation (NASDAQ: BRKRP) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Bruker Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BRKRP on the NASDAQ shows an RSI of 52.31, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $546.31 for the NASDAQ listing.

Key metrics behind Bruker Corporation's NASDAQ-traded stock include a P/E ratio of -84.78 and a market capitalization of 8.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BRKRP on the NASDAQ.

Price Performance (NASDAQ: BRKRP)

1-Day Change
-0.27%
5-Day Change
3.84%
1-Month Change
-1.20%
3-Month Change
28.30%
6-Month Change
43.97%
Year-to-Date (YTD) Change
20.05%
1-Year Change
75.41%
3-Year Change
75.41%
5-Year Change
75.41%
All-Time (Max) Change
75.41%

Contact Information

978 663 3660
40 Manning Road, Billerica, MA, 01821

Company Facts

110,850 Employees
IPO DateSep 4, 2025
CountryUS
Actively Trading

Frequently Asked Questions